ATC code L01#L01A Alkylating agents

{{Short description|Pharmaceutical drug classification}}

{{ATC codes lead|L|01|Antineoplastic agents|vet=add}}

{{anchor|L01A}}L01A Alkylating agents

={{anchor|L01AA}}L01AA Nitrogen mustard analogues=

:L01AA01 Cyclophosphamide

:L01AA02 Chlorambucil

:L01AA03 Melphalan

:L01AA05 Chlormethine

:L01AA06 Ifosfamide

:L01AA07 Trofosfamide

:L01AA08 Prednimustine

:L01AA09 Bendamustine

:L01AA10 Melphalan flufenamide

={{anchor|L01AB}}L01AB Alkyl sulfonates=

:L01AB01 Busulfan

:L01AB02 Treosulfan

:L01AB03 Mannosulfan

={{anchor|L01AC}}L01AC Ethylene imines=

:L01AC01 Thiotepa

:L01AC02 Triaziquone

:L01AC03 Carboquone

={{anchor|L01AD}}L01AD Nitrosoureas=

:L01AD01 Carmustine

:L01AD02 Lomustine

:L01AD03 Semustine

:L01AD04 Streptozocin

:L01AD05 Fotemustine

:L01AD06 Nimustine

:L01AD07 Ranimustine

:L01AD08 Uramustine

={{anchor|L01AG}}L01AG Epoxides=

:L01AG01 Etoglucid

={{anchor|L01AX}}L01AX Other alkylating agents=

:L01AX01 Mitobronitol

:L01AX02 Pipobroman

:L01AX03 Temozolomide

:L01AX04 Dacarbazine

{{anchor|L01B}}L01B Antimetabolites

={{anchor|L01BA}}L01BA Folic acid analogues=

:L01BA01 Methotrexate

:L01BA03 Raltitrexed

:L01BA04 Pemetrexed

:L01BA05 Pralatrexate

={{anchor|L01BB}}L01BB Purine analogues=

:L01BB02 Mercaptopurine

:L01BB03 Tioguanine

:L01BB04 Cladribine

:L01BB05 Fludarabine

:L01BB06 Clofarabine

:L01BB07 Nelarabine

:QL01BB90 Rabacfosadine

={{anchor|L01BC}}L01BC Pyrimidine analogues=

:L01BC01 Cytarabine

:L01BC02 Fluorouracil

:L01BC03 Tegafur

:L01BC04 Carmofur

:L01BC05 Gemcitabine

:L01BC06 Capecitabine

:L01BC07 Azacitidine

:L01BC08 Decitabine

:L01BC09 Floxuridine

:L01BC52 Fluorouracil, combinations

:L01BC53 Tegafur, combinations

:L01BC58 Decitabine, combinations

:L01BC59 Trifluridine, combinations

{{anchor|L01C}}L01C Plant alkaloids and other natural products

={{anchor|L01CA}}L01CA Vinca alkaloids and analogues=

:L01CA01 Vinblastine

:L01CA02 Vincristine

:L01CA03 Vindesine

:L01CA04 Vinorelbine

:L01CA05 Vinflunine

:L01CA06 Vintafolide

={{anchor|L01CB}}L01CB Podophyllotoxin derivatives=

:L01CB01 Etoposide

:L01CB02 Teniposide

={{anchor|L01CC}}L01CC Colchicine derivatives=

:L01CC01 Demecolcine

={{anchor|L01CD}}L01CD Taxanes=

:L01CD01 Paclitaxel

:L01CD02 Docetaxel

:L01CD03 Paclitaxel poliglumex

:L01CD04 Cabazitaxel

:L01CD51 Paclitaxel and encequidar

={{anchor|L01CE}}L01CE Topoisomerase 1 (TOP1) inhibitors=

:L01CE01 Topotecan

:L01CE02 Irinotecan

:L01CE03 Etirinotecan pegol

:L01CE04 Belotecan

={{anchor|L01CX}}L01CX Other plant alkaloids and natural products=

:L01CX01 Trabectedin

={{anchor|L01DA}}L01DA Actinomycines=

:L01DA01 Dactinomycin

={{anchor|L01DC}}L01DC Other cytotoxic antibiotics=

:L01DC01 Bleomycin

:L01DC02 Plicamycin

:L01DC03 Mitomycin

:L01DC04 Ixabepilone

:L01DC05 Utidelone

{{anchor|L01E}}L01E Protein kinase inhibitors

={{anchor|L01EA}}L01EA BCR-ABL tyrosine kinase inhibitors=

:L01EA01 Imatinib

:L01EA02 Dasatinib

:L01EA03 Nilotinib

:L01EA04 Bosutinib

:L01EA05 Ponatinib

:L01EA06 Asciminib

={{anchor|L01EB}}L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors=

:L01EB01 Gefitinib

:L01EB02 Erlotinib

:L01EB03 Afatinib

:L01EB04 Osimertinib

:L01EB05 Rociletinib

:L01EB06 Olmutinib

:L01EB07 Dacomitinib

:L01EB08 Icotinib

:L01EB09 Lazertinib

:L01EB10 Mobocertinib

:L01EB11 Aumolertinib

={{anchor|L01EC}}L01EC B-Raf serine-threonine kinase (BRAF) inhibitors=

:L01EC01 Vemurafenib

:L01EC02 Dabrafenib

:L01EC03 Encorafenib

={{anchor|L01ED}}L01ED Anaplastic lymphoma kinase (ALK) inhibitors=

:L01ED01 Crizotinib

:L01ED02 Ceritinib

:L01ED03 Alectinib

:L01ED04 Brigatinib

:L01ED05 Lorlatinib

={{anchor|L01EE}}L01EE Mitogen-activated protein kinase (MEK) inhibitors=

:L01EE01 Trametinib

:L01EE02 Cobimetinib

:L01EE03 Binimetinib

:L01EE04 Selumetinib

:L01EE05 Mirdametinib

={{anchor|L01EF}}L01EF Cyclin-dependent kinase (CDK) inhibitors=

:L01EF01 Palbociclib

:L01EF02 Ribociclib

:L01EF03 Abemaciclib

={{anchor|L01EG}}L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors=

:L01EG01 Temsirolimus

:L01EG02 Everolimus

:L01EG03 Ridaforolimus

:L01EG04 Sirolimus

={{anchor|L01EH}}L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors=

:L01EH01 Lapatinib

:L01EH02 Neratinib

:L01EH03 Tucatinib

={{anchor|L01EJ}}L01EJ Janus-associated kinase (JAK) inhibitors=

:L01EJ01 Ruxolitinib

:L01EJ02 Fedratinib

:L01EJ03 Pacritinib

:L01EJ04 Momelotinib

={{anchor|L01EK}}L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors=

:L01EK01 Axitinib

:L01EK02 Cediranib

:L01EK03 Tivozanib

:L01EK04 Fruquintinib

={{anchor|L01EL}}L01EL Bruton's tyrosine kinase (BTK) inhibitors=

:L01EL01 Ibrutinib

:L01EL02 Acalabrutinib

:L01EL03 Zanubrutinib

:L01EL04 Orelabrutinib

:L01EL05 Pirtobrutinib

:L01EL06 Tirabrutinib

={{anchor|L01EM}}L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors=

:L01EM01 Idelalisib

:L01EM02 Copanlisib

:L01EM03 Alpelisib

:L01EM04 Duvelisib

:L01EM05 Parsaclisib

={{anchor|L01EN}}L01EN Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors=

:L01EN01 Erdafitinib

:L01EN02 Pemigatinib

:L01EN03 Infigratinib

:L01EN04 Futibatinib

={{anchor|L01EX}}L01EX Other protein kinase inhibitors=

:L01EX01 Sunitinib

:L01EX02 Sorafenib

:L01EX03 Pazopanib

:L01EX04 Vandetanib

:L01EX05 Regorafenib

:L01EX06 Masitinib

:L01EX07 Cabozantinib

:L01EX08 Lenvatinib

:L01EX09 Nintedanib

:L01EX10 Midostaurin

:L01EX11 Quizartinib

:L01EX12 Larotrectinib

:L01EX13 Gilteritinib

:L01EX14 Entrectinib

:L01EX15 Pexidartinib

:L01EX17 Capmatinib

:L01EX18 Avapritinib

:L01EX19 Ripretinib

:L01EX21 Tepotinib

:L01EX22 Selpercatinib

:L01EX23 Pralsetinib

:L01EX24 Surufatinib

:L01EX25 Umbralisib

:L01EX26 Sitravatinib

:L01EX27 Capivasertib

:L01EX28 Repotrectinib

:QL01EX90 Toceranib

{{anchor|L01F}}L01F Monoclonal antibodies and antibody drug conjugates

={{anchor|L01FA}}L01FA CD20 (clusters of differentiation 20) inhibitors=

:L01FA01 Rituximab

:L01FA02 Ofatumumab

:L01FA03 Obinutuzumab

={{anchor|L01FB}}L01FB CD22 (clusters of differentiation 22) inhibitors=

={{anchor|L01FC}}L01FC CD38 (clusters of differentiation 38) inhibitors=

:L01FC01 Daratumumab

:L01FC02 Isatuximab

={{anchor|L01FD}}L01FD HER2 (human epidermal growth factor receptor 2) inhibitors=

={{anchor|L01FE}}L01FE EGFR (epidermal growth factor receptor) inhibitors=

:L01FE01 Cetuximab

:L01FE02 Panitumumab

:L01FE03 Necitumumab

={{anchor|L01FF}}L01FF PD-1/PDL-1 (programmed cell death protein 1/ death ligand 1) inhibitors=

:L01FF01 Nivolumab

:L01FF02 Pembrolizumab

:L01FF03 Durvalumab

:L01FF04 Avelumab

:L01FF05 Atezolizumab

:L01FF06 Cemiplimab

:L01FF07 Dostarlimab

:L01FF08 Prolgolimab

:L01FF09 Tislelizumab

:L01FF10 Retifanlimab

:L01FF11 Sugemalimab

:L01FF12 Serplulimab

:L01FF13 Toripalimab

={{anchor|L01FG}}L01FG VEGF/VEGFR (vascular endothelial growth factor) inhibitors=

:L01FG01 Bevacizumab

:L01FG02 Ramucirumab

={{anchor|L01FX}}L01FX Other monoclonal antibodies and antibody drug conjugates=

:L01FX01 Edrecolomab

:L01FX02 Gemtuzumab ozogamicin

:L01FX03 Catumaxomab

:L01FX04 Ipilimumab

:L01FX05 Brentuximab vedotin

:L01FX06 Dinutuximab beta

:L01FX07 Blinatumomab

:L01FX08 Elotuzumab

:L01FX09 Mogamulizumab

:L01FX10 Olaratumab

:L01FX11 Bermekimab

:L01FX12 Tafasitamab

:L01FX13 Enfortumab vedotin

:L01FX14 Polatuzumab vedotin

:L01FX15 Belantamab mafodotin

:L01FX16 Oportuzumab monatox

:L01FX17 Sacituzumab govitecan

:L01FX18 Amivantamab

:L01FX19 Sabatolimab

:L01FX20 Tremelimumab

:L01FX21 Naxitamab

:L01FX22 Loncastuximab tesirine

:L01FX23 Tisotumab vedotin

:L01FX24 Teclistamab

:L01FX25 Mosunetuzumab

:L01FX26 Mirvetuximab soravtansine

:L01FX27 Epcoritamab

:L01FX28 Glofitamab

:L01FX29 Talquetamab

:L01FX31 Zolbetuximab

:L01FX32 Elranatamab

:L01FX33 Tarlatamab

:L01FX34 Odronextamab

:L01FX35 Datopotamab deruxtecan

:L01FX36 Patritumab deruxtecan

={{anchor|L01FY}}L01FY Combinations of monoclonal antibodies and antibody drug conjugates=

{{anchor|L01X}}L01X Other antineoplastic agents

={{anchor|L01XA}}L01XA Platinum compounds=

:L01XA01 Cisplatin

:L01XA02 Carboplatin

:L01XA03 Oxaliplatin

:L01XA04 Satraplatin

:L01XA05 Polyplatillen

={{anchor|L01XB}}L01XB Methylhydrazines=

:L01XB01 Procarbazine

={{anchor|L01XD}}L01XD Sensitizers used in photodynamic/radiation therapy=

={{anchor|L01XF}}L01XF Retinoids for cancer treatment=

:L01XF01 Tretinoin

:L01XF02 Alitretinoin

:L01XF03 Bexarotene

={{anchor|L01XG}}L01XG Proteasome inhibitors=

:L01XG01 Bortezomib

:L01XG02 Carfilzomib

:L01XG03 Ixazomib

={{anchor|L01XH}}L01XH Histone deacetylase (HDAC) inhibitors=

:L01XH01 Vorinostat

:L01XH02 Romidepsin

:L01XH03 Panobinostat

:L01XH04 Belinostat

:L01XH05 Entinostat

:L01XH06 Tucidinostat

:L01XH07 Resminostat

={{anchor|L01XJ}}L01XJ Hedgehog pathway inhibitors=

:L01XJ01 Vismodegib

:L01XJ02 Sonidegib

:L01XJ03 Glasdegib

={{anchor|L01XK}}L01XK Poly (ADP-ribose) polymerase (PARP) inhibitors =

:L01XK01 Olaparib

:L01XK02 Niraparib

:L01XK03 Rucaparib

:L01XK04 Talazoparib

:L01XK05 Veliparib

:L01XK06 Pamiparib

:L01XK52 Niraparib and abiraterone

={{anchor|L01XL}}L01XL Antineoplastic cell and gene therapy =

={{anchor|L01XM}}L01XM Isocitrate dehydrogenase (IDH) inhibitors=

:L01XM01 Enasidenib

:L01XM02 Ivosidenib

:L01XM03 Olutasidenib

:L01XM04 Vorasidenib

={{anchor|L01XU}}L01XU Other antineoplastic agents (cont.)=

:Empty group

={{anchor|L01XX}}L01XX Other antineoplastic agents=

:L01XX01 Amsacrine

:L01XX02 Asparaginase

:L01XX03 Altretamine

:L01XX05 Hydroxycarbamide

:L01XX07 Lonidamine

:L01XX08 Pentostatin

:L01XX10 Masoprocol

:L01XX11 Estramustine

:L01XX16 Mitoguazone

:L01XX18 Tiazofurine

:L01XX23 Mitotane

:L01XX24 Pegaspargase

:L01XX27 Arsenic trioxide

:L01XX29 Denileukin diftitox

:L01XX33 Celecoxib

:L01XX35 Anagrelide

:L01XX36 Oblimersen

:L01XX40 Omacetaxine mepesuccinate

:L01XX41 Eribulin

:L01XX44 Aflibercept

:L01XX46 Olaparib

:L01XX52 Venetoclax

:L01XX53 Vosaroxin

:L01XX57 Plitidepsin

:L01XX58 Epacadostat

:L01XX66 Selinexor

:L01XX67 Tagraxofusp

:L01XX69 Lurbinectedin

:L01XX72 Tazemetostat

:L01XX73 Sotorasib

:L01XX74 Belzutifan

:L01XX75 Tebentafusp

:L01XX77 Adagrasib

:L01XX78 Navitoclax

:L01XX79 Eflornithine

:L01XX80 Imetelstat

:L01XX81 Nirogacestat

:L01XX82 Darinaparsin

:L01XX83 Para-toluenesulfonamide

:L01XX84 Pelabresib

:L01XX85 Idroxioleic acid

:L01XX86 Calaspargase pegol

:QL01XX91 Tigilanol tiglate

:QL01XX92 Verdinexor

={{anchor|L01XY}}L01XY Combinations of antineoplastic agents=

:L01XY01 Cytarabine and daunorubicin

:L01XY04 Bifikafusp alfa and onfekafusp alfa

References

{{Reflist}}

{{Intracellular chemotherapeutic agents}}

{{Extracellular chemotherapeutic agents}}

L01